Table 3. Prognostic factors for GBC patients at our unit.
| Variables | Univariate regression | Multivariate regression | |||||
|---|---|---|---|---|---|---|---|
| HR | 95% CI | P value | HR | 95% CI | P value | ||
| Acute cholecystitis | 2.59 | 1.11–6.06 | 0.028 | – | – | – | |
| Jaundice | 3.18 | 1.37–7.334 | 0.007 | – | – | – | |
| CA 19.9 ≥500 U/mL | 2.5 | 1.05–5.98 | 0.039 | – | – | – | |
| CEA ≥5 ng/mL | 2.99 | 1.10–8.14 | 0.032 | – | – | – | |
| Other carcinomas | 3.32 | 1.19–9.23 | 0.022 | – | – | – | |
| Stage > II | 10.35 | 2.34–45.75 | 0.002 | 8.58 | 1.786–41.171 | 0.007 | |
| N+ | 6.55 | 2.38–18.03 | <0.001 | – | – | – | |
| LVI | 8.96 | 2.78–28.89 | <0.001 | 4.06 | 1.035–15.918 | 0.045 | |
| Hepatic invasion | 6.86 | 2.51–18.75 | <0.001 | – | – | – | |
| Bile duct invasion | 3.50 | 1.11–11.02 | 0.033 | – | – | – | |
| ≥R1 resection | 11.79 | 3.8–36.6 | <0.001 | – | – | – | |
| Hepatic resection | 0.24 | 0.11–0.67 | <0.001 | 0.288 | 0.091–0.910 | 0.034 | |
GBC, gallbladder carcinoma; CA, carbohydrate antigen; CEA, carcinoembryonic antigen; LVI, lymphovascular invasion.